Article info
PDFEBM opinion and debate
Misleading clinical evidence and systematic reviews on ivermectin for COVID-19
- Correspondence to Nicolás Meza, CIESAL, Universidad de Valparaiso, Viña del Mar, Chile; nicolas.meza{at}uv.cl
Citation
Misleading clinical evidence and systematic reviews on ivermectin for COVID-19
Publication history
- Accepted March 29, 2021
- First published April 22, 2021.
Online issue publication
May 24, 2022
Article Versions
- Previous version (24 May 2022).
- Previous version (24 May 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage